Register for a Clinical Trial

Protocol RHB-104-01
Title Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to Severely Active Crohn’s Disease
Phase III
Area Crohns Disease
Indication

Moderate to Severe Crohn's Disease

Treatment

RHB-104

Requirement

Current Treatment with at least one of the following compounds: 5-ASA, Corticosteroid therapy, AZA, or 6-MP

Trial:
Your First Name:
Your Last Name:
Phone Number:
Address:
City:
State:
ZIP Code:
E-mail Address:
Cancel